Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Pediatrix Medical (MD) Equity Income (2016 - 2025)

Historic Equity Income for Pediatrix Medical (MD) over the last 12 years, with Q3 2025 value amounting to $1.9 million.

  • Pediatrix Medical's Equity Income rose 32224.72% to $1.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.7 million, marking a year-over-year increase of 9449.11%. This contributed to the annual value of $2.3 million for FY2024, which is 1395.24% up from last year.
  • Latest data reveals that Pediatrix Medical reported Equity Income of $1.9 million as of Q3 2025, which was up 32224.72% from $505000.0 recorded in Q2 2025.
  • Pediatrix Medical's Equity Income's 5-year high stood at $1.9 million during Q3 2025, with a 5-year trough of $290000.0 in Q4 2021.
  • Over the past 5 years, Pediatrix Medical's median Equity Income value was $490000.0 (recorded in 2023), while the average stood at $569736.8.
  • Per our database at Business Quant, Pediatrix Medical's Equity Income crashed by 4246.03% in 2021 and then soared by 32224.72% in 2025.
  • Pediatrix Medical's Equity Income (Quarter) stood at $290000.0 in 2021, then skyrocketed by 38.97% to $403000.0 in 2022, then grew by 18.86% to $479000.0 in 2023, then soared by 91.44% to $917000.0 in 2024, then skyrocketed by 104.91% to $1.9 million in 2025.
  • Its Equity Income stands at $1.9 million for Q3 2025, versus $505000.0 for Q2 2025 and $406000.0 for Q1 2025.